Evidence map›Paper›PMID 30169578›Full record

ArticleCardiovascular research2019

Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.

Carlos A Valverde, Gabriela Mazzocchi, Mariano N Di Carlo, Alejandro Ciocci Pardo, Nehuen Salas, María Ines Ragone, Juan I Felice, Alejandra Cely-Ortiz, Alicia E Consolini, Enrique Portiansky and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. LncRNA CCRR maintains CaScience China. Life sciences · 2024
    Article
  6. Article
  7. Review
  8. CaInternational journal of molecular sciences · 2022
    Article
  9. CaPflugers Archiv : European journal of physiology · 2022
    Review
  10. Article
  11. Cellular Mechanisms Underlying the Low Cardiotoxicity of Istaroxime.Journal of the American Heart Association · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. SERCA2a: a key protein in the CaHeart failure reviews · 2020
    Review
  16. Article
  17. Review
  18. Article
  19. Unbalance Between Sarcoplasmic Reticulum CaFrontiers in physiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Carlos A ValverdeCentro de Investigaciones Cardiovasculares 'Dr. Horacio E. Cingolani', CCT-La Plata-CONICET, Facultad de Cs. Médicas, UNLP, 60 y 120 s/n, La Plata CP, Argentina.
Gabriela MazzocchiCentro de Investigaciones Cardiovasculares 'Dr. Horacio E. Cingolani', CCT-La Plata-CONICET, Facultad de Cs. Médicas, UNLP, 60 y 120 s/n, La Plata CP, Argentina.
Mariano N Di CarloCentro de Investigaciones Cardiovasculares 'Dr. Horacio E. Cingolani', CCT-La Plata-CONICET, Facultad de Cs. Médicas, UNLP, 60 y 120 s/n, La Plata CP, Argentina.
Alejandro Ciocci PardoCentro de Investigaciones Cardiovasculares 'Dr. Horacio E. Cingolani', CCT-La Plata-CONICET, Facultad de Cs. Médicas, UNLP, 60 y 120 s/n, La Plata CP, Argentina.
Nehuen SalasCentro de Investigaciones Cardiovasculares 'Dr. Horacio E. Cingolani', CCT-La Plata-CONICET, Facultad de Cs. Médicas, UNLP, 60 y 120 s/n, La Plata CP, Argentina.
María Ines RagoneGrupo de Farmacología Experimental, (GFEYEC), Departamento of Ciencias Biológicas, Facultad de Ciencias Exactas - CONICET., La Plata, Argentina.
Juan I FeliceCentro de Investigaciones Cardiovasculares 'Dr. Horacio E. Cingolani', CCT-La Plata-CONICET, Facultad de Cs. Médicas, UNLP, 60 y 120 s/n, La Plata CP, Argentina.
Alejandra Cely-OrtizCentro de Investigaciones Cardiovasculares 'Dr. Horacio E. Cingolani', CCT-La Plata-CONICET, Facultad de Cs. Médicas, UNLP, 60 y 120 s/n, La Plata CP, Argentina.
Alicia E ConsoliniGrupo de Farmacología Experimental, (GFEYEC), Departamento of Ciencias Biológicas, Facultad de Ciencias Exactas - CONICET., La Plata, Argentina.
Enrique PortianskyLaboratorio de Análisis de Imágenes, Facultad de Cs. Veterinarias, UNLP, La Plata, Argentina.
Susana MoscaCentro de Investigaciones Cardiovasculares 'Dr. Horacio E. Cingolani', CCT-La Plata-CONICET, Facultad de Cs. Médicas, UNLP, 60 y 120 s/n, La Plata CP, Argentina.
Evangelia G KraniasDepartment of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
Xander H T WehrensDepartment of Molecular Physiology and Biophysics, Cardiovascular Research Institute, Center for Space Medicine, Baylor College of Medicine, Houston, TX, USA.
Alicia MattiazziCentro de Investigaciones Cardiovasculares 'Dr. Horacio E. Cingolani', CCT-La Plata-CONICET, Facultad de Cs. Médicas, UNLP, 60 y 120 s/n, La Plata CP, Argentina.
Centro de Investigaciones Cardiovasculares · ARConsejo Nacional de Investigaciones Científicas y Técnicas · ARBaylor College of Medicine · USUniversidad Nacional de La Plata · ARUniversity of Cincinnati Medical Center · US

Funding

Ryanodine receptor regulation in post-operative atrial fibrillationR01HL089598 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI WEHRENS, XANDER H.T. · 2007 to 2022
$6.5M
Regulation of Sarcoplasmic Reticulum Calcium Release in Heart FailureR01HL091947 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI WEHRENS, XANDER H.T. · 2009 to 2019
$3.2M
Determining the Role of Junctophilin-2 in Cardiac DiseaseR01HL117641 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI WEHRENS, XANDER H.T. · 2014 to 2017
$2.3M
Development of novel compounds for the treatment of atrial fibrillationR41HL129570 · NHLBI · ELEX BIOTECH, LLC · PI WEHRENS, XANDER H.T. · 2015 to 2015
$428k
NHLBI NIH HHS R01 HL089598NHLBI NIH HHS R01 HL091947NHLBI NIH HHS R01 HL117641NHLBI NIH HHS R41 HL129570
6 · The paper itself

Abstract

aimsAbnormal Ca2+ release from the sarcoplasmic reticulum (SR), associated with Ca2+-calmodulin kinase II (CaMKII)-dependent phosphorylation of RyR2 at Ser2814, has consistently been linked to arrhythmogenesis and ischaemia/reperfusion (I/R)-induced cell death. In contrast, the role played by SR Ca2+ uptake under these stress conditions remains controversial. We tested the hypothesis that an increase in SR Ca2+ uptake is able to attenuate reperfusion arrhythmias and cardiac injury elicited by increased RyR2-Ser2814 phosphorylation. METHODS AND

resultsWe used WT mice, which have been previously shown to exhibit a transient increase in RyR2-Ser2814 phosphorylation at the onset of reperfusion; mice with constitutive pseudo-phosphorylation of RyR2 at Ser2814 (S2814D) to exacerbate CaMKII-dependent reperfusion arrhythmias and cardiac damage, and phospholamban (PLN)-deficient-S2814D knock-in (SDKO) mice resulting from crossbreeding S2814D with phospholamban knockout deficient (PLNKO) mice. At baseline, S2814D and SDKO mice had structurally normal hearts. Moreover none of the strains were arrhythmic before ischaemia. Upon cardiac I/R, WT, and S2814D hearts exhibited abundant arrhythmias that were prevented by PLN ablation. In contrast, PLN ablation increased infarct size compared with WT and S2814D hearts. Mechanistically, the enhanced SR Ca2+ sequestration evoked by PLN ablation in SDKO hearts prevented arrhythmogenic events upon reperfusion by fragmenting SR Ca2+ waves into non-propagated and non-arrhythmogenic events (mini-waves). Conversely, the increase in SR Ca2+ sequestration did not reduce but rather exacerbated I/R-induced SR Ca2+ leak, as well as mitochondrial alterations, which were greatly avoided by inhibition of RyR2. These results indicate that the increase in SR Ca2+ uptake is ineffective in preventing the enhanced SR Ca2+ leak of PLN ablated myocytes from either entering into nearby mitochondria and/or activating additional CaMKII pathways, contributing to cardiac damage.

conclusionOur results demonstrate that increasing SR Ca2+ uptake by PLN ablation can prevent the arrhythmic events triggered by CaMKII-dependent phosphorylation of RyR2-induced SR Ca2+ leak. These findings underscore the benefits of increasing SERCA2a activity in the face of SR Ca2+ triggered arrhythmias. However, enhanced SERCA2a cannot prevent but rather exacerbates I/R cardiac injury.

Indexed as

Action PotentialsAnimalsArrhythmias, CardiacCalcium-Binding ProteinsCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium SignalingDisease Models, AnimalGene Knockdown TechniquesHeart RateIsolated Heart PreparationMaleMice, Inbred C57BLMice, KnockoutMitochondria, HeartMyocardial InfarctionMyocardial Reperfusion InjuryAtp2a2 protein, mouseCalcium-Binding ProteinsCalcium-Calmodulin-Dependent Protein Kinase Type 2Phospholambanryanodine receptor 2. mouseRyanodine Receptor Calcium Release ChannelSarcoplasmic Reticulum Calcium-Transporting ATPasesArrhythmiasCalciumCalcium wavesCaMKIIPhospholamban

Identifiers

PMID30169578
PMCPMC6383052
OpenAlexW2890009867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.